Immuron (IMRN) Share-based Compensation (2020 - 2021)
Immuron (IMRN) posted quarterly Share-based Compensation of $1.5 million for Q2 2021, up 496.32% year-on-year from $250599.4 in Q2 2020, and up 496.32% on a QoQ basis from -$377061.8 in Q2 2020.
Immuron (IMRN) Share-based Compensation (2020 - 2021) Analysis & Trends
Immuron (IMRN) has reported Share-based Compensation for 2 consecutive years, with $1.5 million the latest figure, recorded in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 6.39 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9.26 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 1.18 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 166.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 257.40 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 87.30 Mn |
| 10 | Immuron | 270.20 Mn | 258.54 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 1.49 Mn |
| Jun 30, 2021 | 1.49 Mn |
| Jun 30, 2020 | -377,061.83 |
| Jun 30, 2020 | -377,061.83 |